The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Retrospective analysis of patients with sentinel lymph node (SLN) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissection (CLND).
 
Zeynep Eroglu
Consulting or Advisory Role - Array BioPharma; Compugen; Regeneron
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Tesaro
 
Nalan Babacan
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Kenneth F. Grossmann
Consulting or Advisory Role - Bristol-Myers Squibb (I); Castle Biosciences; Roche/Genentech
 
Joseph Markowitz
Consulting or Advisory Role - Array Biopharma; Idera; Newlink Genetics
Research Funding - Genoptix (Inst); Macrogenics (Inst); Morphogenesis (Inst); Reata Pharmaceuticals (Inst)
 
Andrew Scott Brohl
Expert Testimony - GlaxoSmithKline (I)
 
Jennifer Cisneros
No Relationships to Disclose
 
Wayne Cruse
No Relationships to Disclose
 
Michael Harrington
No Relationships to Disclose
 
Ricardo Jorge Gonzalez
No Relationships to Disclose
 
Amod Sarnaik
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - B4CC
Research Funding - Genentech (Inst); Iovance Biotherapeutics (Inst); Provectus (Inst)
Patents, Royalties, Other Intellectual Property - Compositions and methods for improving tumor-infiltrating lymphocytes for adoptive cell therapy, filed March 20, 2014 U.S. Patent Application No. 61/955,970 and second Application No. 61/973,002 (Inst)
 
Jonathan S. Zager
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Castle Biosciences; Delcath Systems; Philogen
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Novartis (Inst); Philogen (Inst); Provectus (Inst)
Travel, Accommodations, Expenses - Amgen
 
Vernon K. Sondak
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Castle Biosciences; EMD Serono; Genentech/Roche; Illumina; Merck/Schering Plough; Novartis; OncoSec; Pfizer; Polynoma; Sun Pharma
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Bellicum Pharmaceuticals; Mazor Robotics; Transenterix
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; HUYA Bioscience International; Immunocore; Merck; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)